A risk model for lung cancer incidence

Cancer Prevention Research

Volumn 5, Issue 6, 2012, Pages 834-846

  Hoggart, Clive ^a   Brennan, Paul ^b   Tjonneland, Anne ^c   Vogel, Ulla ^d   Overvad, Kim ^e,f   Østergaard, Jane Nautrup ^e,f   Kaaks, Rudolf ^g   Canzian, Federico ^g   Boeing, Heiner ^g   Steffen, Annika ^h   Trichopoulou, Antonia ⁱ   Bamia, Christina ⁱ   Trichopoulos, Dimitrios ⁱ   Johansson, Mattias ^b   Palli, Domenico ^j   Krogh, Vittorio ^k   Tumino, Rosario ^l   Sacerdote, Carlotta ^m   Panico, Salvatore ⁿ   Boshuizen, Hendriek ^o   Bueno de Mesquita, H Bas ^p   Peeters, Petra H M ^p   Lund, Eiliv ^q   Gram, Inger Torhild ^q   Braaten, Tonje ^q   Rodríguez, Laudina ^r   Agudo, Antonio ^s   Sánchez Cantalejo, Emilio ^t,u   Arriola, Larraitz ^u   Chirlaque, Maria Dolores ^u,w   Barricarte, Aurelio ^v   Rasmuson, Torgny ^x   Khaw, Kay Tee ^y   Wareham, Nicholas ^y   Allen, Naomi E ^z   Riboli, Elio ^a   Vineis, Paolo ^a   more..

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^c INSTITUTE OF CANCER EPIDEMIOLOGY   (Denmark)

^d NATIONAL RESEARCH CENTRE FOR THE WORKING ENVIRONMENT   (Denmark)

^e AARHUS UNIVERSITY   (Denmark)

^f AALBORG UNIVERSITY HOSPITAL   (Denmark)

^g GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^h GERMAN INSTITUTE OF HUMAN NUTRITION   (Germany)

ⁱ UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^j CANCER RESEARCH AND PREVENTION INSTITUTE ISPO   (Italy)

^k NATIONAL CANCER INSTITUTE   (Italy)

^l CIVILE M P AREZZO HOSPITAL   (Italy)

^m ISI FOUNDATION   (Italy)

ⁿ UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^o NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^p UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^q UNIVERSITY OF TROMSØ   (Norway)

^r Health and Health Care Services Council   (Spain)

^s CATALAN INSTITUTE OF ONCOLOGY   (Spain)

^t ANDALUSIAN SCHOOL OF PUBLIC HEALTH   (Spain)

^u CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^v INSTITUTO DE SALUD PÚBLICA DE NAVARRA   (Spain)

^w DEPARTMENT OF EPIDEMIOLOGY   (Spain)

^x UMEÅ UNIVERSITY   (Sweden)

^y ADDENBROOKE S HOSPITAL   (United Kingdom)

^z UNIVERSITY OF OXFORD   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; CANCER INCIDENCE; CANCER MORTALITY; CIGARETTE SMOKING; CLINICAL TRIAL; COHORT ANALYSIS; ENVIRONMENTAL EXPOSURE; FEMALE; GENETIC ASSOCIATION; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MODEL; MULTICENTER STUDY; OCCUPATIONAL EXPOSURE; PREDICTIVE VALUE; PRIORITY JOURNAL; PROBABILITY; PROSPECTIVE STUDY; RECEIVER OPERATING CHARACTERISTIC; RISK MODEL; SURVIVAL;

ADULT; AGED; EUROPE; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; LUNG NEOPLASMS; MALE; MIDDLE AGED; MODELS, STATISTICAL; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; RISK FACTORS; SMOKING; SURVIVAL RATE;

EID: 84866467012     PISSN: 19406207     EISSN: 19406215     Source Type: Journal    
DOI: 10.1158/1940-6207.CAPR-11-0237     Document Type: Article

References (40)

1. American Cancer Society. Cancer facts & figures 2009. Atlanta, GA: American Cancer Society; 2009.
2. GLOBOCAN 2008. Lyon, France: IARC [cited 2010 Nov 25]. Available from: http://globocan.iarc.fr/.
3. Aberle DR, Berg CD, Black WC, Church TR, Fagerstrom RM, et al. The national lung screening trial: overview and study design. Radiology 2011;258:243-53.
4. The National Lung Screening Trial Research Team. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med 2011;365:395-409.
5. Bach PB, Kattan MW, Thornquist MD, Kris MG, Tate RC, Barnett MJ, et al. Variations in lung cancer risk among smokers. J Natl Cancer Inst 2003;95:470-8. (Pubitemid 36432421)
6. Spitz MR, Hong WK,AmosCI,WuX, Schabath MB, Dong Q, et al.Arisk model for prediction of lung cancer. J Natl Cancer Inst 2007;99:715-26. (Pubitemid 47073532)
7. Tammemagi CM, Pinsky PF, Caporaso NE, Kvale PA, Hocking WG, Church TR, et al. Lung cancer risk prediction: Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial models and validation. J Natl Cancer Inst 2011;103:1058-68.
8. Cassidy A, Myles JP, van Tongeren M, Page RD, Liloglou T, Duffy SW, et al. The LLP risk model: an individual risk prediction model for lung cancer. Br J Cancer 2008;98:270-6. (Pubitemid 351161249)
9. Spitz MR, Etzel CJ, Dong Q, Amos CI, Wei Q, Wu X, et al. An expanded risk prediction model for lung cancer. Cancer Prev Res 2008;1:250-4.
10. Riboli E, Hunt KJ, Slimani N, Ferrari P, Norat T, Fahey M, et al. European Prospective Investigation into Cancer and Nutrition (EPIC): study populations and data collection. Public Health Nutr 2002;5:1113-24. (Pubitemid 36313608)
11. Hung RJ, McKay JD, Gaborieau V, Boffetta P, Hashibe M, Zaridze D, et al. A susceptibility locus for lung cancer maps to nicotinic acetylcholine receptor subunit genes on 15q25. Nature 2008;452:633-7. (Pubitemid 351483367)
12. Peto R. Influence of dose and duration of smoking on lung cancer rates. IARC Sci Publ 1986;23-33.
13. Samet JM. The health benefits of smoking cessation. Med Clin North Am 1992;76:399-414.
14. Lubin JH, Blot WJ, Berrino F, Flamant R, Gillis CR, Kunze M, et al. Modifying risk of developing lung cancer by changing habits of cigarette smoking. Br Med J (Clin Res Ed) 1984;288:1953-6. (Pubitemid 14081771)
15. Ebbert JO, Yang P, Vachon CM, Vierkant RA, Cerhan JR, Folsom AR, et al. Lung cancer risk reduction after smoking cessation: observations from a prospective cohort of women. J Clin Oncol 2003;21:921-6. (Pubitemid 46606453)
16. Halpern MT, Gillespie BW, Warner KE. Patterns of absolute risk of lung cancer mortality in former smokers. J Natl Cancer Inst 1993;85:457-64. (Pubitemid 23084090)
17. Lubin JH, Caporaso N, Wichmann HE, Schaffrath-Rosario A, Alavanja MC. Cigarette smoking and lung cancer: modeling effect modification of total exposure and intensity. Epidemiology 2007;18:639-48. (Pubitemid 47263041)
18. Henschke CI, Yip R, Miettinen OS. Women's susceptibility to tobacco carcinogens and survival after diagnosis of lung cancer. JAMA 2006;296:180-4. (Pubitemid 44050371)
19. Zang EA, Wynder EL. Differences in lung cancer risk between men and women: examination of the evidence. J Natl Cancer Inst 1996;88:183-92. (Pubitemid 26065830)
20. Olson JE, Yang P, Schmitz K, Vierkant RA, Cerhan JR, Sellers TA. Differential association of body mass index and fat distribution with three major histologic types of lung cancer: evidence from a cohort of older women. Am J Epidemiol 2002;156:606-15.
21. Yang L, Yang G, Zhou M, Smith M, Ge H, Boreham J, et al. Body mass index and mortality from lung cancer in smokers and nonsmokers: a nationally representative prospective study of 220,000 men in China. Int J Cancer 2009;125:2136-43.
22. Veglia F, Vineis P, Overvad K, Boeing H, Bergmann M, Trichopoulou A, et al. Occupational exposures, environmental tobacco smoke, and lung cancer. Epidemiology 2007;18:769-75. (Pubitemid 350295176)
23. Mao Y, Hu J, Ugnat AM, Semenciw R, Fincham S. Socioeconomic status and lung cancer risk in Canada. Int J Epidemiol 2001;30:809-17.
24. Amos CI, Wu X, Broderick P, Gorlov IP, Gu J, Eisen T, et al. Genome-wide association scan of tag SNPs identifies a susceptibility locus for lung cancer at 15q25.1. Nat Genet 2008;40:616-22. (Pubitemid 351601203)
25. Thorgeirsson TE, Geller F, Sulem P, Rafnar T, Wiste A, Magnusson KP, et al. A variant associated with nicotine dependence, lung cancer and peripheral arterial disease. Nature 2008;452:638-42. (Pubitemid 351483366)
26. McKay JD, Hung RJ, Gaborieau V, Boffetta P, Chabrier A, Byrnes G, et al. Lung cancer susceptibility locus at 5p15.33. Nat Genet 2008;40:1404-6.
27. Wang Y, Broderick P, Webb E, Wu X, Vijayakrishnan J, Matakidou A, et al. Common 5p15.33 and 6p21.33 variants influence lung cancer risk. Nat Genet 2008;40:1407-9.
28. Grambsch P, Therneau T. Proportional hazards tests and diagnostics based on weighted residuals. Biometrika 1994;81:515-26.
29. The R Project for Statistical Computing. [cited 2010 Nov 25]. Available from: http://www.R-project.org.
30. Event history analysis. [cited 2010 Nov 25]. Available from: http://CRAN.R-project.org/package=eha.
31. Key JT, Pericchi LR, Smith AFM. Bayesian model choice: what and why? (with discussion). In:Bernardo JM, Berger JO, Dawid AP, Smith AFM, Editors. Bayesian statistics. Vol 6. Proceedings of the Sixth Valencia International Meeting. Oxford, UK: Oxford Science Publications; 1997. p. 343-70.
32. DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 1988;44:837-45.
33. Robin X, Turck N, Hainard A, Tiberti N, Lisacek F, Sanchez J-C, et al. pROC: an open-source package for R and S+ to analyze and compare ROC curves. BMC Bioinformatics 2011;12:77.
34. Liu M, Kapadia AS, Etzel CJ. Evaluating a new risk marker's predictive contribution in survival models. J Stat Theory Pract 2010;4:845-55.
35. Pencina MJ, AgostinoRB Sr, Agostino RBJr, Vasan RS. Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med 2008;27:157-72. (Pubitemid 351193639)
36. Vineis P, Kogevinas M, Simonato L, Brennan P, Boffetta P. Levelling-off of the risk of lung and bladder cancer in heavy smokers: an analysis based on multicentric case-control studies and a metabolic interpretation. Mutat Res 2000;463:103-10. (Pubitemid 30326801)
37. Boffetta P, Clark S, Shen M, Gislefoss R, Peto R, Andersen A. Serum cotinine level as predictor of lung cancer risk. Cancer Epidemiol Biomarkers Prev 2006;15:1184-8.
38. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Tobacco smoke and involuntary smoking. IARC Monogr Eval Carcinog Risks Hum 2004;83:1-1438.
39. Maher B. Personal genomes: the case of the missing heritability. Nature 2008;456:18-21.
40. Truong T, Hung RJ, Amos CI, Wu X, Bickeböller H, Rosenberger A, et al. Replication of lung cancer susceptibility loci at chromosomes 15q25, 5p15, and 6p21: a pooled analysis from the International Lung Cancer Consortium. J Natl Cancer Inst 2010;102:959-71.